Research-use-only context. This article summarizes published third-party scientific literature and laboratory practice. It is not medical advice, not a therapeutic or performance claim, and not a usage guide. US Prime Peptides products are supplied strictly for in vitro laboratory research and are not for human or veterinary use.
A certificate of analysis (COA) is the document that turns a labeled vial into a tested lot. This article walks through a research-peptide certificate in the order its lines usually appear, explains what each measurement can and cannot show, and ends with a short routine for confirming that a report is genuine and belongs to the vial on the bench.
What a certificate of analysis is, and what it is not
A certificate of analysis is a lot-specific summary of laboratory results. It names the material, the lot, the methods used, the acceptance limits, and whether the sample met them. It describes a sample drawn from one lot at one point in time. It is not a general product specification sheet, not a stability guarantee, and not evidence that the particular vial in your hand was itself opened and tested.
US manufacturing regulation frames the same idea in a useful way. Under 21 CFR 211.84(d)(2), a drug manufacturer may accept a supplier's "report of analysis" instead of repeating every test, but only if it performs at least one specific identity test of its own and validates the supplier's results at suitable intervals. That rule is written for manufacturers, yet it captures the right posture: a certificate is a starting point to be checked, not a conclusion.
Two further points frame everything below. A certificate reports only what a method was asked to find, so a standard panel leaves blind spots such as stereochemistry, aggregation state, and storage history. And the weight a report deserves depends on who issued it: a manufacturer's own quality unit and an unrelated contract laboratory answer slightly different questions, and the strongest documentation set includes both.
The header: product, lot, dates, and laboratory
The header should let a reader tie the report to exactly one material and one lot without guesswork. The table below lists the fields a complete header carries and why each one matters.
| Header field | What it should contain | Why it matters |
|---|---|---|
| Product name and sequence | Common name, one-letter or three-letter sequence, modifications, salt form, molecular formula, theoretical mass | Confirms which molecule and which salt was tested; the theoretical mass is the reference point for the identity line |
| Lot number | The identifier printed on the vial label | Under 21 CFR 210.3(b)(11), a lot number is any distinctive combination of letters, numbers, or symbols from which the complete history of a lot can be determined |
| Labeled quantity | Mass per vial, for example 10 mg | Allows the content line to be read as a mass fraction of a known fill |
| Date of manufacture and date of analysis | Two separate dates | A long gap between them can mean the material sat untested; the analysis date anchors any stability reasoning |
| Date of issue and retest or expiry date | When the report was signed, and when it should be considered stale | A report is a snapshot; a retest date says how long the issuer stands behind it |
| Laboratory identity and report number | Lab name, address, a unique report or job number, analyst and reviewer signatures | The report number is what the laboratory will look up when you call to verify |
What a lot number is for covers label-to-certificate matching and what to do when numbers disagree. As a concrete example, the product page for BPC-157 10 mg posts the lot-matched certificate for the lot currently shipping, so the header fields can be compared with the label before an order is placed.
Identity by mass spectrometry
The identity line states the theoretical mass of the peptide and the mass observed by mass spectrometry, and declares a match if the difference falls within a stated tolerance: a fraction of a dalton on a low-resolution instrument, parts per million on a high-resolution one. Because peptides ionize with several charges, the report may list a deconvoluted neutral mass or individual charge states, and the two forms should agree.
What an intact-mass match proves is that a species of the expected elemental composition dominates the main peak. What it cannot prove is residue order (the same amino acids in a different order weigh the same), stereochemistry (a D-amino-acid substitution does not change the mass), or the absence of co-eluting isobaric impurities. Tandem MS and orthogonal chromatography close some of those gaps. A 2015 AAPS Journal method paper by Zeng and colleagues at the FDA showed that liquid chromatography coupled to high-resolution mass spectrometry could detect related impurities present below 0.1% of the main component in salmon calcitonin, bivalirudin, and exenatide, which is the sensitivity level a good identity and impurity workflow should reach. A fuller walk-through of charge states and isotope patterns is in LC-MS identity confirmation.
Purity by HPLC
The purity line reports the percentage of total integrated peak area contributed by the main peak in a reversed-phase HPLC run at a stated detection wavelength. USP General Chapter <621> calls this quantitation by area normalization: each component's percentage is its peak area divided by the total area of all peaks counted, after excluding solvent and mobile-phase peaks and any peak at or below the disregard limit, which for impurity tests is generally 0.05%.
Three details separate a careful certificate from a vague one. The method should be named: column, gradient, wavelength, run time. The disregard limit and integration approach should be stated or available on request. And area percent assumes every peak absorbs light equally per unit mass, which is often wrong. A 2025 Analytical Chemistry perspective by Kuril argued that assuming a relative response factor of 1.0 for every impurity can over- or under-estimate peptide impurities, and a 2002 Journal of Pharmaceutical and Biomedical Analysis paper by Nussbaum and colleagues demonstrated a nitrogen-specific detector method for measuring those response factors directly. USP <621> itself calls for correction factors when a response factor falls outside 0.8 to 1.2. The arithmetic behind the number, and why 99% area does not mean 99% peptide by mass, is covered in HPLC purity: what area percent does and does not tell you.
Net peptide content, counter-ion, and water
The content line reports what fraction of the powder's mass is actually peptide, as opposed to counter-ions, bound water, and residual salts. It is a different number from purity and is often lower. A 2018 Analytical and Bioanalytical Chemistry study by Melanson and colleagues on a candidate angiotensin II reference material measured the trifluoroacetate counter-ion by fluorine-19 NMR at nearly 25% of the total mass, in a material whose chromatographic purity was high. The methods that produce the content number are amino acid analysis after hydrolysis, ultraviolet absorbance where the sequence contains tryptophan or tyrosine, quantitative NMR, and mass balance.
Which method was used matters for comparability. In a 2019 multi-laboratory study in the Journal of Pharmaceutical and Biomedical Analysis, Li and colleagues at USP compared HPLC assay against a mass-balance-assigned standard, quantitative NMR, and amino acid analysis for oxytocin; the HPLC assay approach showed the lowest between-laboratory variability. A 2023 Pharmaceutical Research report by McCarthy and colleagues described USP's two-step practice: assign a value to bulk material by mass balance, then use that bulk as the standard for the vialed material. A certificate should say "net peptide content" or "peptide content as free base", give the method, and state the salt form. The reasons content runs below purity are worked through in net peptide content vs purity.
The safety panel: endotoxin, sterility, and heavy metals
The remaining lines are lot-level statements about contaminants rather than about the peptide itself. Each has a compendial method, a unit, and a precise meaning for a pass.
| Line | Method named on the certificate | Unit | What a pass means | What it does not mean |
|---|---|---|---|---|
| Bacterial endotoxin | USP <85> Limulus amebocyte lysate (gel-clot, turbidimetric, or chromogenic), or a recombinant reagent method per USP <86> | EU/mg or EU per vial | Endotoxin in the sample tested was below the stated limit, with interference controls valid | Absence of non-endotoxin pyrogens; absence of microorganisms |
| Sterility | USP <71> membrane filtration or direct inoculation, two media, incubation of at least 14 days | No growth / growth | No contaminating microorganism was found in the articles examined | Proof that every untested vial in the lot is sterile; the chapter says so explicitly |
| Heavy metals | ICP-MS, usually for arsenic, cadmium, mercury, and lead | µg/g (ppm) per element | Each element was below its stated limit in the sample digested | Residual solvent or reagent content, which needs a separate gas chromatography test |
A sterility pass and an endotoxin pass are independent: a filtered solution can be free of viable organisms and still carry endotoxin shed from bacteria no longer present. And because both tests consume the sample, both are statements about a drawn sample and its sampling plan, not about any individual sealed vial.
How to verify a report with the issuing laboratory
Verification means confirming with the laboratory, through a channel you found yourself, that it issued that report number for that lot with those results. A few minutes catches the common problems: a report copied from another lot, a re-dated report, or a laboratory that cannot be reached at all.
Record the laboratory name, report number, lot number, and issue date from the PDF. Find the laboratory's contact details independently rather than through a link on the seller's page, and ask it to confirm the report number, lot, date, and headline results. Compare the posted PDF with any copy the laboratory sends; differences in fonts, signatures, or layout are a warning sign. Compare the certificate against the vial label: lot number, product name, and labeled mass should agree exactly. Finally, read the method statements. A credible report names the compendial chapter or an in-house method validated along the lines of USP <1225> or ICH Q2(R2), with specificity for identification, and accuracy, precision, linearity, and range for assay and impurity procedures.
Published market surveys show why this effort is justified. Janvier and colleagues, writing in Talanta in 2018, profiled the ten most frequently encountered falsified polypeptide products on the Belgian market and found related impurities and contaminants behind confident paperwork. Ashraf and colleagues, in a 2024 Journal of Medical Internet Research study, test-purchased NN9535 products from online sellers and assessed packaging, sterility, endotoxin, and LC-MS content, reporting products that did not match their sellers' claims. A certificate that survives a direct check with its issuing laboratory is the simplest defense against both patterns.
Frequently Asked Questions
What does a certificate of analysis for a research peptide include?
A complete certificate carries a header (product, sequence, salt form, lot number, labeled mass, dates, laboratory, and report number), an identity result by mass spectrometry, a purity result by HPLC with the method stated, a net peptide content result with its method, and a contaminant panel covering endotoxin, sterility, and heavy metals, each with its method and acceptance limit.
How do I know if a peptide COA is real?
Contact the issuing laboratory using contact details you located independently and ask it to confirm the report number, lot number, issue date, and results. Compare the certificate's lot number and labeled mass with the vial label, and look for a named method behind each result. A report whose laboratory cannot be reached, or whose report number is unknown to that laboratory, should not be relied on.
Does 99% purity on a COA mean the vial contains 99% peptide by mass?
No. Purity by HPLC is the main peak's share of total chromatographic peak area, which only counts species that absorb at the detection wavelength. Counter-ions, water, and inorganic salts are invisible to that measurement, so a 99% pure powder can contain substantially less than 99% peptide by mass. The net peptide content line, measured by amino acid analysis, UV, or NMR, answers the mass question.
Is a certificate of analysis the same as a product specification sheet?
No. A specification sheet lists the limits a product is supposed to meet; a certificate of analysis reports measured results for one specific lot against those limits, with the date and laboratory.
Citations
- 21 CFR 210.3, Definitions (batch, lot, lot number). Code of Federal Regulations, Title 21. law.cornell.edu/cfr/text/21/210.3
- 21 CFR 211.84, Testing and approval or rejection of components, drug product containers, and closures. Code of Federal Regulations, Title 21. law.cornell.edu/cfr/text/21/211.84
- United States Pharmacopeia. General Chapter <621> Chromatography. USP-NF. doi.usp.org/USPNF/USPNF_M99380_80201_01.html
- United States Pharmacopeia. General Chapter <1225> Validation of Compendial Procedures. USP-NF. doi.usp.org/USPNF/USPNF_M99945_40101_01.html
- United States Pharmacopeia. General Chapter <71> Sterility Tests. USP-NF. doi.usp.org/USPNF/USPNF_M98810_01_01.html
- FDA. Q2(R2) Validation of Analytical Procedures: Guidance for Industry. March 2024. fda.gov
- Zeng K, Geerlof-Vidavisky I, Gucinski A, Jiang X, Boyne MT. Liquid Chromatography-High Resolution Mass Spectrometry for Peptide Drug Quality Control. AAPS J. 2015;17:643-651. PMID 25716148
- Kumar Kuril A. The Critical Need for Implementing RRF in the Accurate Assessment of Impurities in Peptide Therapeutics. Anal Chem. 2025;97:12480-12485. PMID 40499007
- Nussbaum MA, Baertschi SW, Jansen PJ. Determination of relative UV response factors for HPLC by use of a chemiluminescent nitrogen-specific detector. J Pharm Biomed Anal. 2002;27:983-993. PMID 11836061
- Melanson JE, Thibeault MP, Stocks BB, Leek DM, McRae G, Meija J. Purity assignment for peptide certified reference materials by combining qNMR and LC-MS/MS amino acid analysis results: application to angiotensin II. Anal Bioanal Chem. 2018;410:6719-6731. PMID 30143839
- Li C, Bhavaraju S, Thibeault MP, et al. Survey of peptide quantification methods and comparison of their reproducibility: A case study using oxytocin. J Pharm Biomed Anal. 2019;166:105-112. PMID 30640042
- McCarthy D, Han Y, Carrick K, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharm Res. 2023;40:1317-1328. PMID 36949371
- Janvier S, Cheyns K, Canfyn M, et al. Impurity profiling of the most frequently encountered falsified polypeptide drugs on the Belgian market. Talanta. 2018;188:795-807. PMID 30029448
- Ashraf AR, Mackey TK, Vida RG, et al. Multifactor Quality and Safety Analysis of NN9535 Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study. J Med Internet Res. 2024;26:e65440. PMID 39509151
This article is for laboratory research reference only. US Prime Peptides products are supplied strictly for in vitro research. Not for human consumption.
Related research
- What a Lot Number Is For, and How to Match a Vial to Its Certificate
- How to Vet a Research Peptide Vendor: A 12-Point Checklist
- Net Peptide Content vs Purity: Why a 99% Pure Vial Can Hold Less Peptide Than You Think
- HPLC Purity: What 'Area Percent' Does and Does Not Tell You
- Endotoxin Testing Explained: LAL, Recombinant Factor C, and Reading EU per mg
Compliance Notice: US Prime Peptides products are supplied strictly for laboratory and academic research purposes only. They are not intended for human or veterinary consumption, diagnosis, treatment, or prevention of any disease. All content on this page is educational in nature and does not constitute medical advice or product claims. Researchers are responsible for handling these compounds in accordance with their institution’s safety protocols and applicable laws.
